IRIS Accounts Production v25.1.4.42 07995095 director 1.4.24 31.3.25 31.3.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh079950952024-03-31079950952025-03-31079950952024-04-012025-03-31079950952023-03-31079950952023-04-012024-03-31079950952024-03-3107995095ns15:EnglandWales2024-04-012025-03-3107995095ns14:PoundSterling2024-04-012025-03-3107995095ns10:Director12024-04-012025-03-3107995095ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3107995095ns10:SmallEntities2024-04-012025-03-3107995095ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3107995095ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3107995095ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3107995095ns10:FullAccounts2024-04-012025-03-3107995095ns10:CompanySecretary12024-04-012025-03-3107995095ns10:RegisteredOffice2024-04-012025-03-3107995095ns5:CurrentFinancialInstruments2025-03-3107995095ns5:CurrentFinancialInstruments2024-03-3107995095ns5:Non-currentFinancialInstruments2025-03-3107995095ns5:Non-currentFinancialInstruments2024-03-3107995095ns5:ShareCapital2025-03-3107995095ns5:ShareCapital2024-03-3107995095ns5:RetainedEarningsAccumulatedLosses2025-03-3107995095ns5:RetainedEarningsAccumulatedLosses2024-03-3107995095ns5:PlantMachinery2024-04-012025-03-3107995095ns5:ComputerEquipment2024-04-012025-03-3107995095ns5:PlantMachinery2024-03-3107995095ns5:ComputerEquipment2024-03-3107995095ns5:PlantMachinery2025-03-3107995095ns5:ComputerEquipment2025-03-3107995095ns5:PlantMachinery2024-03-3107995095ns5:ComputerEquipment2024-03-3107995095ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-03-3107995095ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-03-31079950951ns10:Director12024-03-31079950951ns10:Director12023-03-31079950951ns10:Director12024-04-012025-03-31079950951ns10:Director12023-04-012024-03-31079950951ns10:Director12025-03-31079950951ns10:Director12024-03-31
REGISTERED NUMBER: 07995095 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2025

for

O - Surg Limited

O - Surg Limited (Registered number: 07995095)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


O - Surg Limited

Company Information
for the Year Ended 31 March 2025







DIRECTOR: Dr Azhar Bakhshi



SECRETARY: Ms Najaf Zehra Shirazi



REGISTERED OFFICE: Unit 3 Cedar Court
1 Royal Oak Yard
London
SE1 3GA



REGISTERED NUMBER: 07995095 (England and Wales)



ACCOUNTANTS: ElanTax.com
Unit 3 Cedar Court
1 Royal Oak Yard
London
SE1 3GA



BANKERS: Royal Bank of Scotland
45 Head Street
Colchester
CO1 1NW

O - Surg Limited (Registered number: 07995095)

Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,185 1,557

CURRENT ASSETS
Debtors 5 39,919 35,731
Investments 6 50,499 -
Cash at bank and in hand 402,283 443,691
492,701 479,422
CREDITORS
Amounts falling due within one year 7 64,671 37,726
NET CURRENT ASSETS 428,030 441,696
TOTAL ASSETS LESS CURRENT
LIABILITIES

430,215

443,253

CREDITORS
Amounts falling due after more than one
year

8

16,224

27,129
NET ASSETS 413,991 416,124

CAPITAL AND RESERVES
Called up share capital 200 200
Retained earnings 413,791 415,924
SHAREHOLDERS' FUNDS 413,991 416,124

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

O - Surg Limited (Registered number: 07995095)

Balance Sheet - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 29 December 2025 and were signed by:





Dr Azhar Bakhshi - Director


O - Surg Limited (Registered number: 07995095)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

O - Surg Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Surgery equipment - 25% on reducing balance
Office equipment - 33% on cost

Taxation
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

4. TANGIBLE FIXED ASSETS
Surgery Office
equipment equipment Totals
£    £    £   
COST
At 1 April 2024 1,889 4,244 6,133
Additions - 1,845 1,845
At 31 March 2025 1,889 6,089 7,978
DEPRECIATION
At 1 April 2024 1,179 3,397 4,576
Charge for year 178 1,039 1,217
At 31 March 2025 1,357 4,436 5,793
NET BOOK VALUE
At 31 March 2025 532 1,653 2,185
At 31 March 2024 710 847 1,557

O - Surg Limited (Registered number: 07995095)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

5. DEBTORS
31.3.25 31.3.24
£    £   
Amounts falling due within one year:
Trade debtors 11,930 8,312

Amounts falling due after more than one year:
Bakhshi & Shirazi Holdings Ltd 27,989 27,419

Aggregate amounts 39,919 35,731

6. CURRENT ASSET INVESTMENTS
31.3.25 31.3.24
£    £   
Unlisted investments 50,499 -

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Tax 55,399 26,000
Directors' current accounts 6,879 9,537
Accrued expenses 2,393 2,189
64,671 37,726

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.3.25 31.3.24
£    £   
Bank loans - 2-5 years 16,224 27,129

9. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

31.3.25 31.3.24
£    £   
Dr Azhar Bakhshi
Balance outstanding at start of year (9,412 ) (2,695 )
Amounts advanced 3,457 1,315
Amounts repaid (924 ) (8,032 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (6,879 ) (9,412 )

O - Surg Limited (Registered number: 07995095)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

10. RELATED PARTY DISCLOSURES

The company was under the control of Mr A Bakhshi, a director and members of his close family throughout the current period. Mr A Bakhshi is personally interested in 37.5% (2024 - 43%) of the company's share capital. In addition, his spouse controls a further 37.5% (2024 - 43%), his daughter 12.5% (2024 - 0%) and his mother 12.5% (2024 - 14%) of the company's issued share capital.